Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
Diabetes
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent news - Diabetes
    Rituximab May Slow Beta-Cell Destruction in Patients With Type 1 Diabetes - (DGNews)
    Are people with negative diabetes screening tests falsely reassured? Parallel group cohort study embedded in the ADDITION (Cambridge) randomised controlled trial - (BMJ)
    Glucose Intolerance During Pregnancy Associated With Postpartum Cardiovascular Risk - (DGNews)
    TopAbstracts in Diabetes 12/01/2009 - (DGNews)
    Rituximab, B-Lymphocyte Depletion, and Preservation of Beta-Cell Function - (N Engl J Med)

    News archive

     Recent webcasts/CME - Diabetes
      Clinical Practice In Type 2 Diabetes: After Metformin And Lifestyle, Then What?
      Diabetes and the Heart: Diabetes and Glycemic Control - Endocrine
      Medication Use for Diabetes, Hypertension, and Hypercholesterolemia from 1988-1994 to 2001-2006
      Diabetes and the Heart: Cardiometabolic Screening and Hospital Care
      Diabetes and the Heart: Diabetes and Glycemic Control - Cardiovascular

      Webcasts/CME archive

       Recent cases - Diabetes
        Transient Anti-GAD Antibody Positivity and Acute Pancreatitis with Pancreas Tail Swelling in a Patient with Susceptible Haplotype for Type 1 Diabetes Mellitus
        Acquired Perforating Dermatosis: Association with Diabetes and Renal Failure
        A Patient Presenting with Symptomatic Hypomagnesemia Caused by Metformin-Induced Diarrhoea: A Case Report
        Absence of Diabetic Retinopathy in a Patient who has had Diabetes Mellitus for 69 Years, and Inadequate Glycemic Control: Case Report
        Gallbladder Edema in Type 1 Diabetic Patient due to Delayed-type Insulin Allergy

        Cases archive
          




        my personal edition > diabetes > news
        divider

          E-Mail this DGReview to a colleague

        DGReview


        Adequate Magnesium Intake Reduces Risk For Cardiovascular Disease Type 1 Diabetics

        A DGReview of :"Magnesium reduces insulin-stimulated glucose uptake and serum lipid concentrations in type 1 diabetes"
        Metabolism: Clinical and Experimental

        01/18/2002
        By Veronica Rose


        Magnesium deficiency found among type 1 diabetics appears to be diet related, according to research in Denmark and the United States.

        Researchers also found an association between magnesium repletion and a decrease in atherogenic lipid fractions and reduced insulin-stimulated glucose uptake.

        Previously, a magnesium deficit among type 1 diabetics had been related to the development of cardiovascular disease. This led researchers from various specialist departments at Odense University Hospital in Odense and the State University of New York Health Science Centre at Brooklyn, New York, to test the hypothesis that these patients experienced deficits in dietary magnesium.

        The researchers also questioned whether risk factors for cardiovascular disease would be reduced if patients were prescribed a long-term oral magnesium supplement.

        Participants included 10 patients with type 1 diabetes and five control subjects who were assigned magnesium (Mg) supplementation. The Mg status, intake and effects then underwent evaluation.

        The muscle Mg content , which had been decreased by 7 percent in patients with diabetes type 1, increased by 5 percent after 24 weeks of oral Mg supplementation. There was a decrease seen in serum total cholesterol, serum low-density lipoprotein-cholesterol and apoliprotein B following Mg supplementation.

        Furthermore, 24 weeks after oral Mg supplementation there was a decrease in insulin-stimulated glucose uptake.

        The researchers established that eight of the 10 diabetic patients had a daily magnesium intake of less than 90 percent of the recommended dose.
        Metabolism Clinical & Experimental Vol 50 No 12. "Magnesium reduces insulin-stimulated glucose uptake and serum lipid concentrations in type 1 diabetes"

        E-Mail this DGReview to a colleague   To print, use this version






        All contents Copyright (c) 1995-2009 Doctor's Guide Publishing Limited. All rights reserved.



        The NTK initiative. Physicians helping physicians identify Need-To-Know science
           Feedback
        Please rate this article: Strongly DISAGREE...Strongly AGREE NTK logo
        Question 1 - Physicians need to become aware of this information as soon as possible. Question 2 - This information is likely to have an impact on the way physicians practice medicine.
        1
        2
        3
        4
        5
        6
        7
        Send